Creative Commons source reading · ALS and frontotemporal degeneration
Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging.
B Ghetti; A L Oblak; B F Boeve; K A Johnson; B C Dickerson; M Goedert
Originally published in Neuropathology and applied neurobiology · 2015-02-01
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Hereditary frontotemporal dementia associated with mutations in the microtubule-associated protein tau gene (MAPT) is a protean disorder. Three neuropathologic subtypes can be recognized, based on the presence of inclusions made of tau isoforms with three and four repeats, predominantly three repeats and mostly four repeats. This is relevant for establishing a correlation between structural magnetic resonance imaging and positron emission tomography using tracers specific for aggregated tau. Longitudinal studies will be essential to determine the evolution of anatomical alterations from the asymptomatic stage to the various phases of disease following the onset of symptoms.
Conclusion
This review emphasizes the protean nature of FTD associated with MAPT mutations, as well as the need for correlating longitudinal clinical and neuropsychological studies with neuroimaging. Ideally, this research should be carried out both before the onset of symptoms and during the disease in individuals with mutations that differentially affect tau isoforms.
Editorial reading guide
- Was the evidence cross-sectional, longitudinal or experimental?
- How did the authors account for age, disease stage and differences among participants?
